Browse Studies — Arctuva

Phase 2

A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants With Late Isolated Microvascular Inflammation (MVI)

In this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and later developed a condition call…

Microvascular Inflammation

Estimated

~$10 – $7,500

BiogenNCT07219043

Phase 4

The Effects of Soluble Guanylyl Cyclase Stimulation on Perioperative Vascular Reactivity and Organ Injury in Cardiac Surgery

The goal of this mechanistic clinical trial is to learn about the effects of medications called soluble guanylyl cyclase stimulators on vascular function and m…

Endothelial DysfunctionVascular DiseasesKidney Injury+2 more

Estimated

~$10 – $6,250

Vanderbilt University Medical CenterNCT05812755

Phase 2

Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

The primary goal of this clinical trial is to test the hypothesis that the drug canakinumab (anti-IL-1B monoclonal antibody) decreases vascular inflammation wh…

Vascular InflammationASCVDASCVD Management

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT06691217

Observational

CaRi-Heart® Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA): A Prospective U.S. Community-Based Study on the Impact of CaRi-Heart® Analysis in Patients Undergoing CCTA for Coronary Artery Disease

This study evaluates the use of CaRi-Heart® analysis, an artificial-intelligence (AI) software tool that measures inflammation in the coronary arteries using i…

Coronary Artery DiseaseAtherosclerosisCardiovascular Inflammation

Estimated

~$10 – $7,500

Corazon Medical PCNCT07220304